p.113 抽出テキスト

ease. J Cardiol 2018; 71: 389-393. PMID: 29108668 213. Aimo A, Januzzi JL Jr, Bayes-Genis A, et al. Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week. J Am Coll Cardiol 2019; 74: 2193-2203. PMID: 31648713 214. Raedle-Hurst T, Mueller M, Meinitzer A, et al. Homoarginine - A prognostic indicator in adolescents and adults with complex congenital heart disease? PLoS One 2017; 12: e0184333. PMID: 28886170 215. Zhang R, Gong J, Wang S, et al. Relationship Between Serum B7- H3 Levels and Prognosis of Congenital Heart Disease in Children. Pediatr Cardiol 2019; 40: 177-181. PMID: 30328478 216. Miyamoto K, Takeuchi D, Inai K, et al. Prognostic value of multiple biomarkers for cardiovascular mortality in adult congenital heart disease: comparisons of single-/two-ventricle physiology, and systemic morphologically right/left ventricles. Heart Vessels 2016; 31: 1834-1847. PMID: 26857388 217. Inai K, Nakanishi T, Nakazawa M. Clinical correlation and prognostic predictive value of neurohumoral factors in patients late after the Fontan operation. Am Heart J 2005; 150: 588-594. PMID: 16169346 218. Motoki N, Ohuchi H, Miyazaki A, et al. Clinical profiles of adult patients with single ventricular physiology. Circ J 2009; 73: 1711- 1716. PMID: 19638711 219. Opotowsky AR, Baraona F, Owumi J, et al. Galectin-3 Is Elevated and Associated With Adverse Outcomes in Patients With Single-Ventricle Fontan Circulation. J Am Heart Assoc 2016; 5: e002706. PMID: 26755550 220. Meyer SL, Wolff D, Ridderbos FS, et al. GDF-15 (Growth Differentiation Factor 15) Is Associated With Hospitalization and Mortality in Patients With a Fontan Circulation. J Am Heart Assoc 2020; 9: e015521. PMID: 32384007 221. Cowley CG, Bradley JD, Shaddy RE. B-type natriuretic peptide levels in congenital heart disease. Pediatr Cardiol 2004; 25: 336-340. PMID: 14735252 222. Hopkins WE, Chen Z, Fukagawa NK, et al. Increased atrial and brain natriuretic peptides in adults with cyanotic congenital heart disease: Enhanced understanding of the relationship between hypoxia and natriuretic peptide secretion. Circulation 2004; 109: 2872-2877. PMID: 15173030 223. Saab FG, Aboulhosn JA. Hemodynamic characteristics of cyanotic adults with single-ventricle physiology without Fontan completion. Congenit Heart Dis 2013; 8: 124-130. PMID: 22891795 224. Diller GP, Alonso-Gonzalez R, Kempny A, et al. B-type natriuretic peptide concentrations in contemporary Eisenmenger syndrome patients: predictive value and response to disease targeting therapy. Heart 2012; 98: 736-742. PMID: 22397941 225. Reardon LC, Williams RJ, Houser LS, et al. Usefulness of serum brain natriuretic peptide to predict adverse events in patients with the Eisenmenger syndrome. Am J Cardiol 2012; 110: 1523-1526. PMID: 22863176 226. Senzaki H, Masutani S, Ishido H, et al. Cardiac rest and reserve function in patients with Fontan circulation. J Am Coll Cardiol 2006; 47: 2528-2535. PMID: 16781384 227. Senzaki H, Iwamoto Y, Ishido H, et al. Ventricular-vascular stiffening in patients with repaired coarctation of aorta: Integrated pathophysiology of hypertension. Circulation 2008; 118 Suppl: S191-S198. PMID: 18824754 228. Vogel M, Sponring J, Cullen S, et al. Regional wall motion and abnormalities of electrical depolarization and repolarization in patients after surgical repair of tetralogy of Fallot. Circulation 2001; 103: 1669-1673. PMID: 11273995 229. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002; 106: 92-99. PMID: 12093776 230. Ohuchi H, Diller GP. Biomarkers in adult congenital heart disease heart failure. Heart Fail Clin 2014; 10: 43-56. PMID: 24275294 231. Dubin AM, Janousek J, Rhee E, et al. Resynchronization therapy in pediatric and congenital heart disease patients: An international multicenter study. J Am Coll Cardiol 2005; 46: 2277-2283. PMID: 16360058 232. Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology/ American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 2017; 136: e137-e161. PMID: 28455343 233. Friedberg MK. Imaging right-left ventricular interactions. JACC Cardiovasc Imaging 2018; 11: 755-771. PMID: 29747850 234. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for

the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Devel- oped with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2016; 18: 891-975. PMID: 27207191 235. Masutani S, Saiki H, Kurishima C, et al. Heart failure with pre-

served ejection fraction in children: Hormonal imbalance between aldosterone and brain natriuretic peptide. Circ J 2013; 77: 2375- 2382. PMID: 23728067 236. Masutani S, Kuwata S, Kurishima C, et al. Ventricular-vascular dynamics in pediatric patients with heart failure and preserved ejection fraction. Int J Cardiol 2016; 225: 306-312. PMID: 27744267 237. Vaikunth SS, Lui GK. Heart failure with reduced and preserved ejection fraction in adult congenital heart disease. Heart Fail Rev 2020; 25: 569-581. PMID: 31873841 238. 日本循環器学会 / 日本心不全学会.急性・慢性心不全診療ガイドライン(2017年改訂版).https://www.j-circ.or.jp/cms/wp-content/ uploads/2017/06/JCS2017_tsutsui_h.pdf 239. Granger CB, McMurray JJ, Yusuf S, et al. CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial. Lancet 2003; 362: 772-776. PMID: 13678870 240. Packer M, Bristow MR, Cohn JN, et al. U.S. Carvedilol Heart Failure Study Group. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996; 334: 1349-1355. PMID: 8614419 241. McMurray JJV, Solomon SD, Inzucchi SE, et al. DAPA-HF Trial Committees and Investigators. Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 2019; 381: 1995-2008. PMID: 31535829 242. Armstrong PW, Pieske B, Anstrom KJ, et al. VICTORIA Study Group. Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction. N Engl J Med 2020; 382: 1883-1893. PMID: 32222134 243. Abraham WT, Adams KF, Fonarow GC, et al. ADHERE Scientific Advisory Committee and Investigators. In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: An analysis from the Acute Decompensated Heart Failure National Registry (ADHERE). J Am Coll Cardiol 2005; 46: 57-64. PMID: 15992636 244. Miike H, Ohuchi H, Hayama Y, et al. Systemic Artery Vasoconstrictor Therapy in Fontan Patients with High Cardiac Output-Heart Failure: A Single-Center Experience. Pediatr Cardiol 2021; 42: 700- 706. PMID: 33416919 245. Lowes BD, Tsvetkova T, Eichhorn EJ, et al. Milrinone versus dobutamine in heart failure subjects treated chronically with carvedilol. Int J Cardiol 2001; 81: 141-149. PMID: 11744130 246. Vismara LA, Leaman DM, Zelis R. The effects of morphine on venous tone in patients with acute pulmonary edema. Circulation 1976; 54: 335-337. PMID: 939031 247. Bouchardy J, Therrien J, Pilote L, et al. Atrial arrhythmias in adults with congenital heart disease. Circulation 2009; 120: 1679-1686. PMID: 19822808 248. Opotowsky AR, Siddiqi OK, Webb GD. Trends in hospitalizations for adults with congenital heart disease in the U.S. J Am Coll Cardiol 2009; 54: 460-467. PMID: 19628123 249. Drakopoulou M, Nashat H, Kempny A, et al. Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension. Heart 2018; 104: 1963-1969. PMID: 29776964 250. Budts W, Börjesson M, Chessa M, et al. Physical activity in adolescents and adults with congenital heart defects: individualized exercise prescription. Eur Heart J 2013; 34: 3669-3674. PMID: 24204010 251. Shiina Y, Matsumoto N, Okamura D, et al. Sarcopenia in adults with congenital heart disease: Nutritional status, dietary intake, and resistance training. J Cardiol 2019; 74: 84-89. PMID: 30713126 252. Inuzuka R, Diller GP, Borgia F, et al. Comprehensive use of cardiopulmonary exercise testing identifies adults with congenital heart disease at increased mortality risk in the medium term. Circulation 2012; 125: 250-259. PMID: 22147905 253. Ishikawa Y, Ishikawa S, Sagawa K, et al. Favorable Effects of Oxygen Inhalation in Patients After Bidirectional Glenn Procedure as Assessed by Cardiovascular Magnetic Resonance Flow Measurement. Circ J 2016; 80: 1378-1385. PMID: 27194372 254. Harada G, Takeuchi D, Inai K, et al. Prevalence and risk factors of sleep apnea in adult patients with congenital heart disease. Cardiol Young 2019; 29: 576-582. PMID: 31030704 255. 日本循環器学会.循環器病の診断と治療に関するガイドライン

(2008-2009年度合同研究班報告):循環器領域における睡眠呼吸障害の診断・治療に関するガイドライン.Circ J 2010; 74 Suppl II: 963-1051. https://www.j-circ.or.jp/cms/wp-content/uploads/ 2020/02/JCS2010momomura.h.pdf